Details for: FXYD5

Gene ID: 53827

Gene Type:  Protein-coding  - A gene that serves as a template for producing a messenger RNA (mRNA) molecule, which is then translated into a functional protein.

Symbol: FXYD5

Ensembl ID: ENSG00000089327

Description: FXYD domain containing ion transport regulator 5

Selected Context(s):  Overall

Cell Significance Landscape

Contexts:

Associated with

Significant Cells

Cell Significance Index (CSI) scores for the chosen context(s)

  • hematopoietic stem cell CL0000037
    CSI 108.24
    rCSI 71.95%
    PRS 6.8
  • central memory CD4-positive, alpha-beta T cell CL0000904
    CSI 96.56
    rCSI 57.02%
    PRS 7.93
  • central memory CD8-positive, alpha-beta T cell CL0000907
    CSI 94.73
    rCSI 63.82%
    PRS 6.88
  • common myeloid progenitor CL0000049
    CSI 86.53
    rCSI 69.96%
    PRS 5.6
  • granulocyte monocyte progenitor cell CL0000557
    CSI 84.7
    rCSI 73.34%
    PRS 6.35
  • group 3 innate lymphoid cell CL0001071
    CSI 82.32
    rCSI 61.85%
    PRS 5.87
  • CD4-positive helper T cell CL0000492
    CSI 81.34
    rCSI 61.53%
    PRS 7.96
  • megakaryocyte-erythroid progenitor cell CL0000050
    CSI 78.34
    rCSI 70.74%
    PRS 5.04
  • pancreatic A cell CL0000171
    CSI 74.44
    rCSI 77.98%
    PRS 6.08
  • T follicular helper cell CL0002038
    CSI 71.04
    rCSI 53.16%
    PRS 9.32
  • CD4-positive, alpha-beta memory T cell CL0000897
    CSI 68.8
    rCSI 49.39%
    PRS 7.78
  • CD16-positive, CD56-dim natural killer cell, human CL0000939
    CSI 66.39
    rCSI 44.25%
    PRS 15.89
  • CD14-low, CD16-positive monocyte CL0002396
    CSI 64.6
    rCSI 49.77%
    PRS 5.16
  • naive thymus-derived CD8-positive, alpha-beta T cell CL0000900
    CSI 63.66
    rCSI 44.71%
    PRS 16.65
  • T-helper 17 cell CL0000899
    CSI 61.18
    rCSI 48.58%
    PRS 10.11
  • mucosal invariant T cell CL0000940
    CSI 60.25
    rCSI 48.68%
    PRS 12.57
  • plasmablast CL0000980
    CSI 57.93
    rCSI 45.57%
    PRS 6.79
  • class switched memory B cell CL0000972
    CSI 54.63
    rCSI 40.78%
    PRS 9.67
  • naive B cell CL0000788
    CSI 54.58
    rCSI 46.82%
    PRS 14.01
  • promyelocyte CL0000836
    CSI 54.09
    rCSI 78.01%
    PRS 7.95
  • CD16-negative, CD56-bright natural killer cell, human CL0000938
    CSI 52.2
    rCSI 39.14%
    PRS 17
  • elicited macrophage CL0000861
    CSI 51.7
    rCSI 47.47%
    PRS 6.54
  • effector memory CD4-positive, alpha-beta T cell CL0000905
    CSI 51.48
    rCSI 70.13%
    PRS 14.31
  • CD4-positive, alpha-beta thymocyte CL0000810
    CSI 50.16
    rCSI 40.18%
    PRS 10.53
  • CD4-positive, CD25-positive, alpha-beta regulatory T cell CL0000792
    CSI 49.8
    rCSI 48.91%
    PRS 9.11
  • naive thymus-derived CD4-positive, alpha-beta T cell CL0000895
    CSI 49.61
    rCSI 62.34%
    PRS 29.43
  • activated CD4-positive, alpha-beta T cell CL0000896
    CSI 48.78
    rCSI 45.1%
    PRS 10.46
  • promonocyte CL0000559
    CSI 48.04
    rCSI 82.3%
    PRS 7.65
  • CD1c-positive myeloid dendritic cell CL0002399
    CSI 47.79
    rCSI 57.72%
    PRS 6.71
  • activated CD8-positive, alpha-beta T cell, human CL0001049
    CSI 45.42
    rCSI 77.7%
    PRS 12.38
  • activated type II NK T cell CL0000931
    CSI 43.48
    rCSI 48.94%
    PRS 9.4
  • CD8-positive, CD28-negative, alpha-beta regulatory T cell CL0000920
    CSI 41.69
    rCSI 83.11%
    PRS 9.8
  • memory B cell CL0000787
    CSI 40.81
    rCSI 40.3%
    PRS 24.49
  • early lymphoid progenitor CL0000936
    CSI 38.98
    rCSI 34.23%
    PRS 6.4
  • CD8-positive, alpha-beta memory T cell CL0000909
    CSI 37.23
    rCSI 38.89%
    PRS 18.19
  • gamma-delta T cell CL0000798
    CSI 35.93
    rCSI 42.2%
    PRS 48.57
  • extravillous trophoblast CL0008036
    CSI 35.55
    rCSI 43.97%
    PRS 4.99
  • common dendritic progenitor CL0001029
    CSI 34.88
    rCSI 43.77%
    PRS 7.26
  • non-classical monocyte CL0000875
    CSI 34.25
    rCSI 54.89%
    PRS 18.88
  • T-helper 1 cell CL0000545
    CSI 33.39
    rCSI 60.27%
    PRS 17.01
  • mature B cell CL0000785
    CSI 33.16
    rCSI 28.82%
    PRS 7.02
  • conventional dendritic cell CL0000990
    CSI 29.87
    rCSI 24.93%
    PRS 18.41
  • naive T cell CL0000898
    CSI 29.27
    rCSI 20.37%
    PRS 8.26
  • regulatory T cell CL0000815
    CSI 29.11
    rCSI 33.75%
    PRS 19.21
  • plasmacytoid dendritic cell, human CL0001058
    CSI 28.49
    rCSI 19.89%
    PRS 6.01
  • mature T cell CL0002419
    CSI 26.07
    rCSI 20.28%
    PRS 8.21
  • classical monocyte CL0000860
    CSI 25.4
    rCSI 37.66%
    PRS 52.76
  • CD4-positive, alpha-beta T cell CL0000624
    CSI 24.83
    rCSI 31.78%
    PRS 73.8
  • endothelial cell of artery CL1000413
    CSI 24.68
    rCSI 36.15%
    PRS 32.86
  • activated CD8-positive, alpha-beta T cell CL0000906
    CSI 24
    rCSI 23.59%
    PRS 16.97
  • CD4-positive, alpha-beta cytotoxic T cell CL0000934
    CSI 23.73
    rCSI 32.6%
    PRS 12.26
  • CD8-positive, alpha-beta memory T cell, CD45RO-positive CL0001203
    CSI 23.11
    rCSI 28%
    PRS 8.38
  • alveolar macrophage CL0000583
    CSI 22.9
    rCSI 37.72%
    PRS 6.7
  • mature NK T cell CL0000814
    CSI 22.7
    rCSI 29.03%
    PRS 26
  • innate lymphoid cell CL0001065
    CSI 21.76
    rCSI 44.93%
    PRS 9.22
  • CD14-positive, CD16-positive monocyte CL0002397
    CSI 21.75
    rCSI 28.5%
    PRS 8.01
  • CD14-positive monocyte CL0001054
    CSI 21.25
    rCSI 26.46%
    PRS 8.31
  • fraction A pre-pro B cell CL0002045
    CSI 20.59
    rCSI 23.57%
    PRS 11.84
  • plasmacytoid dendritic cell CL0000784
    CSI 20.58
    rCSI 20.85%
    PRS 35.33
  • effector CD8-positive, alpha-beta T cell CL0001050
    CSI 20.26
    rCSI 15.41%
    PRS 7.54
  • CD8-positive, alpha-beta cytotoxic T cell CL0000794
    CSI 19.72
    rCSI 23.54%
    PRS 9.95
  • hematopoietic multipotent progenitor cell CL0000837
    CSI 19.38
    rCSI 46.64%
    PRS 8.99
  • capillary endothelial cell CL0002144
    CSI 18.02
    rCSI 33.02%
    PRS 34.61
  • effector memory CD8-positive, alpha-beta T cell CL0000913
    CSI 17.97
    rCSI 16.37%
    PRS 8.91
  • helper T cell CL0000912
    CSI 17.47
    rCSI 24.71%
    PRS 8.38
  • mononuclear phagocyte CL0000113
    CSI 17.37
    rCSI 38.23%
    PRS 6.26
  • alternatively activated macrophage CL0000890
    CSI 16.63
    rCSI 20.91%
    PRS 8.8
  • myeloid leukocyte CL0000766
    CSI 16.6
    rCSI 15.31%
    PRS 5.78
  • precursor B cell CL0000817
    CSI 16.24
    rCSI 14.22%
    PRS 7.71
  • granulocyte CL0000094
    CSI 15.85
    rCSI 24.22%
    PRS 7.16
  • keratinocyte CL0000312
    CSI 15.81
    rCSI 13.25%
    PRS 6.83
  • T cell CL0000084
    CSI 15.4
    rCSI 30.1%
    PRS 56.95
  • group 2 innate lymphoid cell CL0001069
    CSI 15.33
    rCSI 82.95%
    PRS 20.16
  • CD8-positive, alpha-beta thymocyte CL0000811
    CSI 15.3
    rCSI 23.86%
    PRS 14.63
  • skin fibroblast CL0002620
    CSI 15.09
    rCSI 13.01%
    PRS 9.45
  • pro-B cell CL0000826
    CSI 14.8
    rCSI 12.26%
    PRS 5.71
  • megakaryocyte CL0000556
    CSI 14.6
    rCSI 63.33%
    PRS 10.61
  • transitional stage B cell CL0000818
    CSI 14.58
    rCSI 47.72%
    PRS 17.41
  • myeloid lineage restricted progenitor cell CL0000839
    CSI 14.52
    rCSI 74.98%
    PRS 11.47
  • B cell CL0000236
    CSI 14.36
    rCSI 19.22%
    PRS 30.58
  • dendritic cell CL0000451
    CSI 14.08
    rCSI 17.35%
    PRS 19.31
  • double negative thymocyte CL0002489
    CSI 13.63
    rCSI 9.48%
    PRS 6.69
  • blood vessel endothelial cell CL0000071
    CSI 13.63
    rCSI 28.28%
    PRS 5.7
  • unswitched memory B cell CL0000970
    CSI 13.36
    rCSI 11.24%
    PRS 9.52
  • hematopoietic precursor cell CL0008001
    CSI 13.17
    rCSI 13.55%
    PRS 9.27
  • natural killer cell CL0000623
    CSI 13.11
    rCSI 25.41%
    PRS 64.04
  • lymphoid lineage restricted progenitor cell CL0000838
    CSI 12.79
    rCSI 49.8%
    PRS 9.44
  • inflammatory macrophage CL0000863
    CSI 12.74
    rCSI 21.76%
    PRS 11.84
  • memory T cell CL0000813
    CSI 12.49
    rCSI 24.05%
    PRS 13.06
  • mast cell CL0000097
    CSI 12.45
    rCSI 26.89%
    PRS 32.29
  • myeloid cell CL0000763
    CSI 12.35
    rCSI 50.85%
    PRS 30.39
  • vein endothelial cell CL0002543
    CSI 11.96
    rCSI 32.63%
    PRS 25.52
  • Langerhans cell CL0000453
    CSI 11.91
    rCSI 18.19%
    PRS 10.05
  • pulmonary artery endothelial cell CL1001568
    CSI 11.8
    rCSI 16.05%
    PRS 8.8
  • macrophage CL0000235
    CSI 11.54
    rCSI 20.99%
    PRS 27.02
  • myofibroblast cell CL0000186
    CSI 11.5
    rCSI 15.92%
    PRS 8.24
  • plasma cell CL0000786
    CSI 11.43
    rCSI 14.99%
    PRS 29.68
  • glutamatergic neuron CL0000679
    CSI 11.33
    rCSI 23.29%
    PRS 6.3
  • monocyte CL0000576
    CSI 11.3
    rCSI 20.42%
    PRS 16.31
  • erythroblast CL0000765
    CSI 11.27
    rCSI 29.9%
    PRS 9.73
  • hepatic stellate cell CL0000632
    CSI -14.6
    rCSI -54.7%
    PRS 4.9%
  • vascular associated smooth muscle cell CL0000359
    CSI -11.3
    rCSI -36.5%
    PRS 7.0%
  • secretory cell CL0000151
    CSI -5.0
    rCSI -5.2%
    PRS 5.9%
  • kidney interstitial alternatively activated macrophage CL1000695
    CSI -4.2
    rCSI -11.0%
    PRS 6.5%
  • blood vessel smooth muscle cell CL0019018
    CSI -4.2
    rCSI -33.8%
    PRS 6.1%
  • Kupffer cell CL0000091
    CSI -3.7
    rCSI -8.5%
    PRS 5.6%
  • lung pericyte CL0009089
    CSI -3.5
    rCSI -9.1%
    PRS 6.9%
  • endocardial cell CL0002350
    CSI -3.0
    rCSI -14.2%
    PRS 9.0%
  • pulmonary capillary endothelial cell CL4028001
    CSI -2.1
    rCSI -4.0%
    PRS 9.2%
  • peripheral nervous system neuron CL2000032
    CSI -1.8
    rCSI -2.5%
    PRS 5.1%
  • alveolar adventitial fibroblast CL4028006
    CSI -1.4
    rCSI -2.2%
    PRS 5.8%
  • basal-myoepithelial cell of mammary gland CL0002324
    CSI -1.3
    rCSI -2.4%
    PRS 12.8%
  • type B pancreatic cell CL0000169
    CSI 0.0
    rCSI 0.1%
    PRS 5.3%
  • pluripotent stem cell CL0002248
    CSI 0.2
    rCSI 5.1%
    PRS 13.8%
  • pancreatic D cell CL0000173
    CSI 0.2
    rCSI 0.2%
    PRS 6.2%
  • mesenchymal cell CL0008019
    CSI 0.3
    rCSI 0.6%
    PRS 5.8%
  • epithelial cell of urethra CL1000296
    CSI 0.3
    rCSI 7.1%
    PRS 20.2%
  • pancreatic epsilon cell CL0005019
    CSI 0.3
    rCSI 1.4%
    PRS 14.3%
  • chondrocyte CL0000138
    CSI 0.3
    rCSI 0.5%
    PRS 5.2%
  • endothelial cell of venule CL1000414
    CSI 0.5
    rCSI 4.0%
    PRS 32.4%
  • group 3 innate lymphoid cell, human CL0001078
    CSI 0.5
    rCSI 10.7%
    PRS 73.9%
  • collagen secreting cell CL0000667
    CSI 0.6
    rCSI 3.2%
    PRS 28.5%
  • cord blood hematopoietic stem cell CL2000095
    CSI 0.6
    rCSI 10.8%
    PRS 44.4%
  • epithelial cell of esophagus CL0002252
    CSI 0.6
    rCSI 5.7%
    PRS 22.9%
  • pro-T cell CL0000827
    CSI 0.7
    rCSI 15.4%
    PRS 39.1%
  • transit amplifying cell CL0009010
    CSI 0.8
    rCSI 1.2%
    PRS 9.3%
  • alveolar type 1 fibroblast cell CL4028004
    CSI 0.8
    rCSI 0.9%
    PRS 6.7%
  • luminal epithelial cell of mammary gland CL0002326
    CSI 0.8
    rCSI 1.5%
    PRS 8.7%
  • respiratory basal cell CL0002633
    CSI 0.8
    rCSI 0.9%
    PRS 6.7%
  • lung microvascular endothelial cell CL2000016
    CSI 0.9
    rCSI 17.8%
    PRS 20.5%
  • lung resident memory CD4-positive, alpha-beta T cell CL4033038
    CSI 1.0
    rCSI 9.5%
    PRS 52.8%
  • NKp44-negative group 3 innate lymphoid cell, human CL0001080
    CSI 1.0
    rCSI 30.0%
    PRS 60.9%
  • lung neuroendocrine cell CL1000223
    CSI 1.0
    rCSI 1.4%
    PRS 6.6%
  • cytotoxic T cell CL0000910
    CSI 1.0
    rCSI 5.6%
    PRS 8.8%
  • myeloid dendritic cell CL0000782
    CSI 1.1
    rCSI 1.5%
    PRS 8.4%
  • basal cell of epithelium of trachea CL1000348
    CSI 1.1
    rCSI 8.0%
    PRS 18.6%
  • tracheal goblet cell CL1000329
    CSI 1.2
    rCSI 2.6%
    PRS 11.7%
  • B-1 B cell CL0000819
    CSI 1.2
    rCSI 31.6%
    PRS 32.6%
  • vasa recta descending limb cell CL1001285
    CSI 1.4
    rCSI 10.9%
    PRS 25.8%
  • vascular leptomeningeal cell CL4023051
    CSI 1.4
    rCSI 2.4%
    PRS 4.4%
  • endothelial cell of placenta CL0009092
    CSI 1.5
    rCSI 7.4%
    PRS 7.8%
  • B-2 B cell CL0000822
    CSI 1.5
    rCSI 32.0%
    PRS 34.9%
  • goblet cell CL0000160
    CSI 1.5
    rCSI 1.5%
    PRS 6.0%
  • squamous epithelial cell CL0000076
    CSI 1.6
    rCSI 3.7%
    PRS 7.6%
  • pancreatic acinar cell CL0002064
    CSI 1.6
    rCSI 2.2%
    PRS 6.2%
  • vasa recta ascending limb cell CL1001131
    CSI 1.6
    rCSI 7.4%
    PRS 25.4%
  • antibody secreting cell CL0000946
    CSI 1.7
    rCSI 7.7%
    PRS 25.8%
  • Hofbauer cell CL3000001
    CSI 1.9
    rCSI 3.6%
    PRS 7.1%
  • placental villous trophoblast CL2000060
    CSI 2.0
    rCSI 3.1%
    PRS 5.4%
  • intraepithelial lymphocyte CL0002496
    CSI 2.1
    rCSI 5.8%
    PRS 26.9%
  • foveolar cell of stomach CL0002179
    CSI 2.1
    rCSI 4.5%
    PRS 9.3%
  • duct epithelial cell CL0000068
    CSI 2.2
    rCSI 3.2%
    PRS 6.1%
  • tissue-resident macrophage CL0000864
    CSI 2.2
    rCSI 10.2%
    PRS 15.0%
  • syncytiotrophoblast cell CL0000525
    CSI 2.2
    rCSI 6.3%
    PRS 11.6%
  • IgM plasma cell CL0000986
    CSI 2.3
    rCSI 10.5%
    PRS 30.3%
  • decidual natural killer cell, human CL0002343
    CSI 2.5
    rCSI 25.2%
    PRS 47.5%
  • prostate gland microvascular endothelial cell CL2000059
    CSI 2.5
    rCSI 59.5%
    PRS 21.5%
  • double-positive, alpha-beta thymocyte CL0000809
    CSI 2.5
    rCSI 2.6%
    PRS 8.2%
  • germinal center B cell CL0000844
    CSI 2.6
    rCSI 7.6%
    PRS 15.2%
  • dendritic cell, human CL0001056
    CSI 2.7
    rCSI 4.1%
    PRS 6.6%
  • double negative T regulatory cell CL0011024
    CSI 2.9
    rCSI 54.4%
    PRS 43.9%
  • neural crest cell CL0011012
    CSI 2.9
    rCSI 2.3%
    PRS 3.9%
  • M cell of gut CL0000682
    CSI 3.0
    rCSI 3.1%
    PRS 10.2%
  • smooth muscle cell CL0000192
    CSI 3.0
    rCSI 7.2%
    PRS 19.6%
  • club cell CL0000158
    CSI 3.4
    rCSI 4.9%
    PRS 6.8%
  • activated CD4-positive, alpha-beta T cell, human CL0001043
    CSI 3.4
    rCSI 8.1%
    PRS 38.3%
  • microcirculation associated smooth muscle cell CL0008035
    CSI 3.4
    rCSI 9.8%
    PRS 6.5%
  • conjunctival epithelial cell CL1000432
    CSI 3.5
    rCSI 5.4%
    PRS 5.7%
  • lung ciliated cell CL1000271
    CSI 3.6
    rCSI 4.1%
    PRS 4.2%
  • pancreatic PP cell CL0002275
    CSI 3.6
    rCSI 14.2%
    PRS 10.2%
  • respiratory hillock cell CL4030023
    CSI 3.6
    rCSI 6.4%
    PRS 9.9%
  • metallothionein-positive alveolar macrophage CL4033042
    CSI 3.6
    rCSI 39.0%
    PRS 27.5%
  • respiratory epithelial cell CL0002368
    CSI 3.6
    rCSI 22.1%
    PRS 19.2%
  • erythroid progenitor cell CL0000038
    CSI 3.7
    rCSI 21.0%
    PRS 9.0%
  • paneth cell CL0000510
    CSI 3.8
    rCSI 5.6%
    PRS 9.0%
  • colon macrophage CL0009038
    CSI 4.2
    rCSI 19.3%
    PRS 12.6%
  • type EC enteroendocrine cell CL0000577
    CSI 4.2
    rCSI 14.9%
    PRS 9.4%
  • CD8-alpha-alpha-positive, alpha-beta intraepithelial T cell CL0000915
    CSI 4.4
    rCSI 20.0%
    PRS 21.4%
  • megakaryocyte progenitor cell CL0000553
    CSI 4.4
    rCSI 80.7%
    PRS 15.3%
  • enterocyte CL0000584
    CSI 4.5
    rCSI 7.3%
    PRS 9.3%
  • fibroblast of lung CL0002553
    CSI 4.6
    rCSI 4.3%
    PRS 5.8%
  • endothelial cell of vascular tree CL0002139
    CSI 4.7
    rCSI 25.5%
    PRS 13.4%
  • small pre-B-II cell CL0000954
    CSI 4.8
    rCSI 4.6%
    PRS 12.3%
  • cerebral cortex endothelial cell CL1001602
    CSI 5.0
    rCSI 8.6%
    PRS 4.4%
  • endothelial cell of pericentral hepatic sinusoid CL0019022
    CSI 5.0
    rCSI 15.4%
    PRS 11.1%
  • basal cell CL0000646
    CSI 5.1
    rCSI 6.8%
    PRS 6.2%
  • large pre-B-II cell CL0000957
    CSI 5.2
    rCSI 14.9%
    PRS 10.1%
  • adventitial cell CL0002503
    CSI 5.3
    rCSI 12.6%
    PRS 9.3%
  • pancreatic stellate cell CL0002410
    CSI 5.5
    rCSI 31.9%
    PRS 8.6%
  • perivascular cell CL4033054
    CSI 5.5
    rCSI 7.5%
    PRS 6.5%
  • intestinal epithelial cell CL0002563
    CSI 5.6
    rCSI 5.8%
    PRS 6.0%
  • platelet CL0000233
    CSI 5.6
    rCSI 23.0%
    PRS 15.9%
  • pre-conventional dendritic cell CL0002010
    CSI 5.7
    rCSI 75.4%
    PRS 20.1%
  • intestine goblet cell CL0019031
    CSI 5.8
    rCSI 5.2%
    PRS 5.7%
  • endothelial cell of uterus CL0009095
    CSI 6.0
    rCSI 43.6%
    PRS 16.2%
  • myeloid dendritic cell, human CL0001057
    CSI 6.0
    rCSI 33.9%
    PRS 18.7%
  • alpha-beta T cell CL0000789
    CSI 6.0
    rCSI 7.1%
    PRS 8.9%
  • mature alpha-beta T cell CL0000791
    CSI 6.2
    rCSI 22.3%
    PRS 9.9%
  • natural T-regulatory cell CL0000903
    CSI 6.5
    rCSI 12.3%
    PRS 16.4%
  • pancreatic ductal cell CL0002079
    CSI 6.6
    rCSI 12.8%
    PRS 5.8%

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration

Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.

Comma-separated if multiple.
Comma-separated if multiple.

Legend:
  • Query Gene
  • Node Color (Target Cell CSI, relative to current network):
    • Very High
    • High
    • Medium
    • Low
    • Very Low
    • CSI N/A
  • Node Size: Proportional to Target Cell CSI magnitude
  • STRING PPI Edge
  • Shared Pathway Edge (ONTOLOGY)

Loading network (please wait)...

Other Information

This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.

## Summary [FXYD5](/details-gene/53827) is a protein-coding gene located on chromosome 19 that encodes FXYD domain-containing ion transport regulator 5. This protein is a member of the FXYD family, known for modulating the activity of Na+/K+-ATPases. Functionally, [FXYD5](/details-gene/53827) is implicated in regulating sodium and potassium ion transport, cell adhesion, and actin cytoskeleton organization. Expression data reveals its significant role primarily within the hematopoietic system, with notably high significance scores in [hematopoietic stem cell](/details-cell/CL0000037)s, progenitor cells, and various subsets of memory and helper T cells. The protein is also known as Dysadherin, a glycoprotein linked to the downregulation of E-cadherin, suggesting a role in cellular adhesion and metastatic processes in cancer ([Link](https://doi.org/10.1073/pnas.012425299)). ## Cellular Roles and Expression Landscape **Overall**, the expression profile of [FXYD5](/details-gene/53827) highlights its profound importance in the hematopoietic and immune systems. The gene shows the highest significance in primitive hematopoietic cells, including [hematopoietic stem cell](/details-cell/CL0000037) (CSI: 108.24), [common myeloid progenitor](/details-cell/CL0000049) (CSI: 86.53), and [megakaryocyte-erythroid progenitor cell](/details-cell/CL0000050) (CSI: 78.34). This pattern suggests a fundamental role in the maintenance and differentiation of blood cell lineages, a finding supported by its initial discovery in CD34+ hematopoietic stem/progenitor cells ([Link](https://doi.org/10.1101/gr.140200)). Beyond hematopoiesis, [FXYD5](/details-gene/53827) is a key marker for mature lymphocytes, particularly within the adaptive immune system. It is highly significant in [central memory CD4-positive, alpha-beta T cell](/details-cell/CL0000904) (CSI: 96.56), [central memory CD8-positive, alpha-beta T cell](/details-cell/CL0000907) (CSI: 94.73), and other specialized T cell subsets like [CD4-positive helper T cell](/details-cell/CL0000492) and [T follicular helper cell](/details-cell/CL0002038). Its presence in innate immune cells, such as [group 3 innate lymphoid cell](/details-cell/CL0001071) and [CD16-positive, CD56-dim natural killer cell, human](/details-cell/CL0000939), further broadens its immunological relevance. Conversely, the gene's significance is consistently low or negative in non-hematopoietic cell types. This includes structural and stromal cells like [hepatic stellate cell](/details-cell/CL0000632) (CSI: -14.59) and [vascular associated smooth muscle cell](/details-cell/CL0000359) (CSI: -11.26), as well as endothelial cells and [peripheral nervous system neuron](/details-cell/CL2000032)s. This restricted expression pattern underscores its specialized function within the immune and hematopoietic compartments. ## Pathways and Molecular Function The functional annotations for [FXYD5](/details-gene/53827) align closely with its observed cellular roles. Its primary molecular function relates to the regulation of ion transport, as indicated by Gene Ontology terms such as `sodium ion transport` ([GO:0006814](https://www.ebi.ac.uk/QuickGO/term/GO:0006814)), `potassium ion transport` ([GO:0006813](https://www.ebi.ac.uk/QuickGO/term/GO:0006813)), and `sodium channel regulator activity` ([GO:0017080](https://www.ebi.ac.uk/QuickGO/term/GO:0017080)). This function is critical for maintaining cellular homeostasis and membrane potential, processes essential for the proliferation and activation of hematopoietic and immune cells. One study demonstrated its role in modulating Na+ absorption in airway epithelia, with increased levels in cystic fibrosis ([Link](https://doi.org/10.1152/ajplung.00430.2007)). In addition to ion transport, [FXYD5](/details-gene/53827) is involved in cell-cell interactions and cytoskeletal dynamics. It is annotated with `cadherin binding` ([GO:0045296](https://www.ebi.ac.uk/QuickGO/term/GO:0045296)) and `negative regulation of calcium-dependent cell-cell adhesion` ([GO:0046588](https://www.ebi.ac.uk/QuickGO/term/GO:0046588)). This is consistent with research identifying [FXYD5](/details-gene/53827) as Dysadherin, a protein that down-regulates E-cadherin function and promotes cancer metastasis ([Link](https://doi.org/10.1073/pnas.012425299)). Its association with `actin binding` ([GO:0003779](https://www.ebi.ac.uk/QuickGO/term/GO:0003779)) and `microvillus assembly` ([GO:0030033](https://www.ebi.ac.uk/QuickGO/term/GO:0030033)) further suggests a role in linking cell surface adhesion events to intracellular signaling and cellular morphology, which are vital for immune cell migration and activation. ## Research Directions The dual roles of [FXYD5](/details-gene/53827) in fundamental ion transport and cell adhesion, combined with its specific expression in hematopoietic cells, suggest several avenues for future investigation. **Proposed Hypotheses:** 1. Given its high significance in hematopoietic stem and progenitor cells, [FXYD5](/details-gene/53827) may be a critical regulator of hematopoietic lineage commitment. Its modulation of ion channels could influence the cellular response to differentiation cues, thereby controlling the balance between myeloid and lymphoid development. 2. The high expression of [FXYD5](/details-gene/53827) in central memory T cells, coupled with its function as Dysadherin, suggests it plays a key role in immune cell trafficking and tissue residency. It may modulate the adhesive properties of memory T cells, facilitating their entry into and retention within peripheral tissues or lymphoid organs. 3. In the context of hematological malignancies, aberrant expression or function of [FXYD5](/details-gene/53827) could contribute to leukemic cell survival and dissemination by altering both ion homeostasis and cell adhesion, potentially representing a novel mechanism of chemoresistance or metastasis. **Experimental Approach:** To test the hypothesis that [FXYD5](/details-gene/53827) regulates hematopoietic lineage commitment (Hypothesis 1), one could utilize a CRISPR-Cas9 knockout or knockdown approach in primary human CD34+ [hematopoietic stem cell](/details-cell/CL0000037)s. These modified cells could then be cultured in vitro under conditions that promote differentiation towards either myeloid or lymphoid lineages. The resulting cell populations could be analyzed by single-cell RNA-sequencing (scRNA-seq) and multi-color flow cytometry to determine if the loss of [FXYD5](/details-gene/53827) skews differentiation, impairs the formation of specific progenitor populations, or affects overall cell viability and proliferation. **Therapeutic Potential:** [FXYD5](/details-gene/53827) presents a compelling, albeit complex, therapeutic target. As a plasma membrane protein, it is readily accessible to antibody-based therapies or small molecules. In oncology, where its role as Dysadherin promotes metastasis, **inhibition** of [FXYD5](/details-gene/53827) function could be a valuable anti-metastatic strategy, particularly in cancers that overexpress it. Conversely, in diseases like cystic fibrosis where ion transport is defective, targeted **activation** or modulation of [FXYD5](/details-gene/53827) activity could potentially restore ion channel function. The challenge lies in developing therapies that are specific to the pathological context, avoiding disruption of its crucial functions in the healthy immune and hematopoietic systems.

Genular Protein ID: 1775809277

Symbol: FXYD5_HUMAN

Name: FXYD domain-containing ion transport regulator 5

UniProtKB Accession Codes:

Database IDs:

Citations:

PubMed ID: 11342114

Title: A cDNA from human bone marrow encoding a protein exhibiting homology to the ATP11/PLM/MAT8 family of transmembrane proteins.

PubMed ID: 11342114

DOI: 10.1016/s0167-4781(00)00251-7

PubMed ID: 11756660

Title: Dysadherin, a cancer-associated cell membrane glycoprotein, down-regulates E-cadherin and promotes metastasis.

PubMed ID: 11756660

DOI: 10.1073/pnas.012425299

PubMed ID: 11042152

Title: Cloning and functional analysis of cDNAs with open reading frames for 300 previously undefined genes expressed in CD34+ hematopoietic stem/progenitor cells.

PubMed ID: 11042152

DOI: 10.1101/gr.140200

PubMed ID: 12975309

Title: The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment.

PubMed ID: 12975309

DOI: 10.1101/gr.1293003

PubMed ID: 15057824

Title: The DNA sequence and biology of human chromosome 19.

PubMed ID: 15057824

DOI: 10.1038/nature02399

PubMed ID: 15489334

Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).

PubMed ID: 15489334

DOI: 10.1101/gr.2596504

PubMed ID: 18263667

Title: FXYD5 modulates Na+ absorption and is increased in cystic fibrosis airway epithelia.

PubMed ID: 18263667

DOI: 10.1152/ajplung.00430.2007

Sequence Information:

  • Length: 178
  • Mass: 19472
  • Checksum: 7429C04838B75AA1
  • Sequence:
  • MSPSGRLCLL TIVGLILPTR GQTLKDTTSS SSADSTIMDI QVPTRAPDAV YTELQPTSPT 
    PTWPADETPQ PQTQTQQLEG TDGPLVTDPE THKSTKAAHP TDDTTTLSER PSPSTDVQTD 
    PQTLKPSGFH EDDPFFYDEH TLRKRGLLVA AVLFITGIII LTSGKCRQLS RLCRNRCR

Genular Protein ID: 1591861194

Symbol: F5H4X8_HUMAN

Name: N/A

UniProtKB Accession Codes:

Database IDs:

Citations:

PubMed ID: 11237011

Title: Initial sequencing and analysis of the human genome.

PubMed ID: 11237011

DOI: 10.1038/35057062

PubMed ID: 15057824

Title: The DNA sequence and biology of human chromosome 19.

PubMed ID: 15057824

DOI: 10.1038/nature02399

PubMed ID: 15496913

Title: Finishing the euchromatic sequence of the human genome.

PubMed ID: 15496913

DOI: 10.1038/nature03001

PubMed ID: 22814378

Title: N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.

PubMed ID: 22814378

DOI: 10.1073/pnas.1210303109

Sequence Information:

  • Length: 194
  • Mass: 21092
  • Checksum: DC72E64276C81AA4
  • Sequence:
  • MSPSGRLCLL TIVGLILPTR GQTLKDTTSS SSADSTIMDI QVPTRAPDAV YTELQPTSPT 
    PTWPADETPQ PQTQTQQLEG TDGPLVTDPE THKSTKAAHP TDDTTTLSER PSPSTDVQTD 
    PQTLKPSGFH EDDPFFYDEH TLRKRGLLVA AVLFITGIII LTSENWGWVG RTPRPGGGLM 
    TEGWVLKGPW AILF